跳至主要内容
临床试验/DRKS00017654
DRKS00017654已完成未知

Multimodal pain therapy with relapse prevention - MMS-RFP

AOK-Die Gesundheitskasse für Niedersachsen0 个研究点目标入组 297 人开始时间: 2019年8月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
297

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 62 Years(—)
性别
All

入选标准

  • AOK insured persons resident in the cities of Emden, Delmenhorst and Oldenburg or in the districts of Ammerland, Oldenburg, Leer, Friesland, Wittmund, Aurich, Wesermarsch, Emsland and Cloppenburg who are entitled to payment for sickness and have been unable to work for at least 28 days due to back pain (ICD M40-M54 except M45, M46 and M49).

排除标准

  • Exclusion criteria are the main hospital diagnoses psychological and behavioral disorders (ICD F00-F99; 6 months before AU (incapacity to work)), malignant neoplasms (ICD C00-C97; 12 months before AU) and injuries (ICD S00-S99; 12 months before AU), the diagnoses paraparesis and paraplegia, tetraparesis and tetraplegia (ICD G82) and an age = 62 years.

研究者

发起方
AOK-Die Gesundheitskasse für Niedersachsen

相似试验